More News: Tremelimumab Does Not Prolong Overall Survival in Malignant Mesothelioma
View web version
Breaking News
Some Patients With Terminal Cancer Receive Unnecessary Aggressive Treatment
Study authors noted that the high rate of hospitalization and aggressive treatment may be a consequence of insurance "structure and incentives."
More News
Tremelimumab Does Not Prolong Overall Survival in Malignant Mesothelioma
Anti-CD19 CAR-T Cells May Be Safe and Effective in Chronic Lymphocytic Leukemia
Infection Poses Serious Threat to Patients With Myeloma Post-ASCT
Viewpoint
The Adverse Effects of Sarcoma Treatment in Cancer Survivors
By
Fact Sheet
Low-fat Diet and Breast Cancer
By

Want to receive emails specific to your profession and specialty? Click here to complete your profile.





Subscribe
If you were sent this by a colleague and wish to subscribe to Weekly highlights, please click here.

Unsubscribe
To unsubscribe from the Weekly Highlights click here.
To manage your entire Cancer Therapy Advisor profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All Cancer Therapy Advisor newsletters are sent from the domain "email.cancertherapyadvisor.com". When configuring e-mail or spam filter rules, please use this domain name.

© 2017 Haymarket Media Inc
275 7th Avenue, 10th Floor
New York, NY 10001